Silver price stock jumps: SLV rallies as silver nears record highs and CME tightens margin rules
13 January 2026
1 min read

Silver price stock jumps: SLV rallies as silver nears record highs and CME tightens margin rules

NEW YORK, Jan 13, 2026, 10:07 ET — Regular session

  • SLV jumped over 4% in early New York trading, with silver hovering close to record levels.
  • CME announced it will switch precious-metals margin calculations to a percentage of notional value following Tuesday’s close.
  • December’s U.S. inflation figures bolstered bets that the Fed will keep rates unchanged this month.

The iShares Silver Trust (SLV) jumped 4.4% to $80.59 Tuesday morning, riding a fresh surge in silver prices.

Spot silver climbed 2.3% to $86.94 an ounce earlier, briefly touching a new high of $87.16. The metal’s sharp rally has traders fixated on volatility just as much as its direction. 1

Volatility is shaking up trade mechanics. On Jan. 12, CME Clearing announced it will shift margins for gold, silver, platinum, and palladium from fixed dollar amounts to a percentage of notional value. These changes take effect after Tuesday’s close. (Margins refer to the cash traders put down as collateral for futures positions.)

The metals rally is hitting resistance from the rate story again. U.S. consumer prices climbed 0.3% in December and were up 2.7% year-over-year, with core inflation rising 0.2% monthly and 2.6% annually, Reuters reported. This data “cemented expectations” that the Federal Reserve will hold rates steady later this month. 2

Silver has acted both as a risk gauge and a hedge recently. Safe-haven buying surged this week after the Trump administration stepped up pressure on Fed Chair Jerome Powell. A fund manager at Jupiter Asset Management noted that “when silver captures flow, it really runs.” 3

Tracking flows into the largest U.S. silver-backed product is straightforward. As of Jan. 12, the iShares Silver Trust held 16,347.95 tonnes of silver and had 579.75 million shares outstanding, according to iShares. 4

Silver miners tracked the metal’s rise. Pan American Silver climbed 2.3%, First Majestic picked up roughly 2.0%, and Hecla Mining added 2.1% in early trading.

The risk here is that the leverage which fueled the rally could flip into selling pressure. Rising margin calls might push some traders to dump positions fast, while a more hawkish Fed tone would dull interest in non-yielding metals if bets on rate cuts diminish.

Traders are focused on futures action heading into the CME margin switch after Tuesday’s close. The next major event is the Fed’s Jan. 27–28 meeting, where rates are widely expected to hold steady between 3.50% and 3.75%.

Stock Market Today

GOOG stock price: Alphabet’s $185 billion AI spend plan keeps Google shares on edge into Monday

GOOG stock price: Alphabet’s $185 billion AI spend plan keeps Google shares on edge into Monday

7 February 2026
New York, Feb 7, 2026, 09:34 EST — Market closed. Alphabet’s non-voting Class C shares (GOOG) closed down 2.48% at $323.10 on Friday, extending a pullback after the Google parent flagged a sharp jump in spending tied to artificial intelligence. 1 With U.S. markets shut for the weekend, the near-term test is whether investors keep treating Big Tech’s AI build-out as a cost problem before it becomes a growth story. A Reuters review of the week’s trading showed fresh jitters around 2026 outlays across the sector, and SanJac Alpha chief investment officer Andrew Wells said the AI trade “got too
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Apple stock today: Creator Studio debut and Gemini Siri deal keep AAPL in play ahead of earnings
Previous Story

Apple stock today: Creator Studio debut and Gemini Siri deal keep AAPL in play ahead of earnings

Dow Jones today: DJIA slips from record as Visa and banks weigh after CPI
Next Story

Dow Jones today: DJIA slips from record as Visa and banks weigh after CPI

Go toTop